These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19723156)

  • 1. An unusual triple-negative breast carcinoma.
    Shousha S; Peston D; Gojis O; Palmieri C
    Histopathology; 2009 Sep; 55(3):364-6. PubMed ID: 19723156
    [No Abstract]   [Full Text] [Related]  

  • 2. Triple-negative breast cancers: unique clinical presentations and outcomes.
    Billar JA; Dueck AC; Stucky CC; Gray RJ; Wasif N; Northfelt DW; McCullough AE; Pockaj BA
    Ann Surg Oncol; 2010 Oct; 17 Suppl 3():384-90. PubMed ID: 20853062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality indicators for the care of breast cancer in vulnerable elders.
    Naeim A; Sawhney R; MacLean CH; Sanati H
    J Am Geriatr Soc; 2007 Oct; 55 Suppl 2():S258-69. PubMed ID: 17910546
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive ductal carcinoma of the breast with the "triple-negative" phenotype: prognostic implications of EGFR immunoreactivity.
    Viale G; Rotmensz N; Maisonneuve P; Bottiglieri L; Montagna E; Luini A; Veronesi P; Intra M; Torrisi R; Cardillo A; Campagnoli E; Goldhirsch A; Colleoni M
    Breast Cancer Res Treat; 2009 Jul; 116(2):317-28. PubMed ID: 18839307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple-negative breast carcinoma in women from Vietnam and the United States: characterization of differential marker expression by tissue microarray.
    Williams DJ; Cohen C; To TV; Page AJ; Lawson D; Sussman ZM; Nassar A
    Hum Pathol; 2009 Aug; 40(8):1176-81. PubMed ID: 19368951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection and treatment of ductal carcinoma of the breast].
    Semiglazov VV; Tabagua TT; Matsko DE
    Vopr Onkol; 2011; 57(6):699-701. PubMed ID: 22416383
    [No Abstract]   [Full Text] [Related]  

  • 8. Metaplastic variant of invasive micropapillary breast carcinoma: a unique triple negative phenotype.
    Aggarwal G; Reid MD; Sharma S
    Int J Surg Pathol; 2012 Oct; 20(5):488-93. PubMed ID: 22334616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer metastatic to the gastric wall.
    Wysocka K; Okoń K; Matyja A
    Pol J Pathol; 2011 Dec; 62(4):282-5. PubMed ID: 22408820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The presence of alveolar structures in invasive ductal NOS breast carcinoma is associated with lymph node metastasis.
    Zavyalova MV; Perelmuter VM; Vtorushin SV; Denisov EV; Litvyakov NV; Slonimskaya EM; Cherdyntseva NV
    Diagn Cytopathol; 2013 Mar; 41(3):279-82. PubMed ID: 22102485
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathological definition of triple negative breast cancer.
    Viale G; Bottiglieri L
    Eur J Cancer; 2009 Sep; 45 Suppl 1():5-10. PubMed ID: 19775600
    [No Abstract]   [Full Text] [Related]  

  • 12. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
    Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P
    Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A proposed anatomical explanation for perineural spread of breast adenocarcinoma to the brachial plexus.
    Hébert-Blouin MN; Amrami KK; Loukas M; Spinner RJ
    Clin Anat; 2011 Jan; 24(1):101-5. PubMed ID: 21154646
    [No Abstract]   [Full Text] [Related]  

  • 14. Vascular invasion in triple-negative carcinoma of the breast identified by endothelial lymphatic and blood vessel markers.
    Kuroda H; Nakai M; Ohnisi K; Ishida T; Kuroda M; Itoyama S
    Int J Surg Pathol; 2010 Oct; 18(5):324-9. PubMed ID: 21068066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of oestrogen and progesterone receptor status in HER-2 positive breast carcinomas and correlation with outcome.
    Francis G; Beadle G; Thomas S; Mengersen K; Stein S
    Pathology; 2006 Oct; 38(5):391-8. PubMed ID: 17008275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast carcinoma with chondroid differentiation: a clinicopathologic study of 21 triple negative (ER-, PR-, Her2/neu-) cases.
    Gwin K; Wheeler DT; Bossuyt V; Tavassoli FA
    Int J Surg Pathol; 2010 Feb; 18(1):27-35. PubMed ID: 19282292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pure or mixed-type invasive lobular carcinoma?
    Bulut N; Dede DS; Sari E; Altundag K
    Hum Pathol; 2008 Jul; 39(7):1121; author reply 1121. PubMed ID: 18570979
    [No Abstract]   [Full Text] [Related]  

  • 18. Concurrent primary angiosarcoma and invasive ductal carcinoma in the same breast.
    Ni Y; Xie X; Bu H; Zhang Z; Wei B; Yin L; Chen M; Chen H; Zhang H
    J Clin Pathol; 2013 Mar; 66(3):263-4. PubMed ID: 23172554
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparison of clinicopathologic characteristics and prognosis of triple-negative with Her-2-overexpressing breast cancer].
    Wang YJ; Wang N; Wang B; Qin WX; Xue CY
    Zhonghua Zhong Liu Za Zhi; 2009 May; 31(5):346-50. PubMed ID: 19799082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlated expression of erbB-3 with hormone receptor expression and favorable clinical outcome in invasive ductal carcinomas of the breast.
    Lee Y; Cho S; Seo JH; Shin BK; Kim HK; Kim I; Kim A
    Am J Clin Pathol; 2007 Dec; 128(6):1041-9. PubMed ID: 18024331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.